Drug Approvals by the Medicines Control Council in South Africa of Merck & Co. Inc. Original Data : South African Medicines Price Registry

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our goal is to lead the way to a healthier future. But we also care about how we get there together. As a company whose products touch the lives and well being of people around the world, we hold ourselves to a high standard. And we expect others to hold us to that same high standard. We believe in operating openly, honestly and with the highest degree of ethics and integrity. This includes: making sure that the compa...
Our goal is to lead the way to a healthier future. But we also care about how we get there together. As a company whose products touch the lives and well being of people around the world, we hold ourselves to a high standard. And we expect others to hold us to that same high standard. We believe in operating openly, honestly and with the highest degree of ethics and integrity. This includes: making sure that the company complies with all applicable laws and regulations globally.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Merck Drive, P.O. Box 100 Whitehouse Station, NJ 08889-0100
Telephone
Telephone
+1 732 422 7800
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

CPhI Worldwide, Milan

CPhI Worldwide, Milan

Not Confirmed

envelop Contact Supplier

CPhI Worldwide, Milan

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”
This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

Impressions: 1975

https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

#SpeakPharma With Veranova
10 Sep 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices
The US is in the midst of yet another, or perhaps the most, polarizing Presidential election. The two candidates have highly divergent personas, records, visions and views. That gets reflected in their starkly different visions for the healthcare system.Healthcare is the second most important issue for voters in the 2024 US elections, with only the economy ranking higher, according to the Pew Research Center.In this week’s PharmaFlow, we look at the past approaches of both the contenders — Democratic presidential nominee Kamala Harris and Republican contender Donald Trump — towards healthcare, and what the two presidencies could mean for the US healthcare industry.Both Harris and Trump have a rare point of agreement — that the US government should act on reducing high drug prices. But have they spelt out how they will make healthcare more accessible? Our analysis should give you some answers.Abortion remains a pivotal issue, may shape broader discussions on healthcareTrump takes pride in the fact that he played an important role in overturning Roe v. Wade, a ruling that protected the abortion rights of women across America. Trump did that by selecting Supreme Court justices who were instrumental in overturning it. Two and a half years after Roe v. Wade was overturned, Trump faces an electorate that largely seems to favor abortion rights — according to Pew Research, 63 percent respondents say abortion should be legal in all or most cases, while 36 percent say it should be illegal in all or most cases.Candidates’ stances on abortion access, including the regulation on medications like mifepristone, are being scrutinized by both supporters and opponents of abortion rights. In June this year, the US Supreme Court had unanimously rejected a case to restrict access to the abortion drug mifepristone. The demand for its ban had been raised by an anti-abortion group in Texas.Of late, there have been reports of Republicans trying to distance themselves from aggressive anti-abortion ideas coming from its party men and allies. Aiming to carve-out a political middle ground, Trump has said that abortion policy should be made by the states. Despite Trump’s softening of stance, abortion rights is likely to not only affect voter turnout, but also shape broader discussions on healthcare and women’s rights.Affordable Care Act: Harris to strengthen it, Trump has ‘concepts of a plan’ to replace itHarris has been all for expanding and strengthening the Affordable Care Act (ACA). She has promised to “make affordable healthcare a right, not a privilege.”Trump, on the other hand, had made attempts during his presidency to repeal and replace the ACA, arguing that it provided “lousy healthcare.” While those efforts ultimately failed in the Senate, Trump succeeded in weakening the ACA by eliminating the individual mandate penalty through the 2017 Tax Cuts and Jobs Act.In a potential second term, Trump might renew efforts to dismantle or significantly alter the ACA. Although he has not presented a comprehensive replacement plan, he said during the Presidential debate held on September 9 that he has “concepts of a plan.”Drug prices: Harris to accelerate Medicare price cuts; Trump to focus on genericsHarris has had an aggressive stance on reducing prescription drug costs. Her tie-breaking vote on the Inflation Reduction Act gave Medicare the power to negotiate lower drug prices with pharmaceutical companies.Harris has pledged to accelerate those negotiations, once she becomes President, to cover more drugs and further lower prices for Americans. She also intends to extend the US$ 35 cap on insulin and the US$ 2,000 cap on out-of-pocket spending for seniors to all Americans, not just those on Medicare.Harris plans to make permanent the Biden-Harris tax credit enhancements that have already lowered healthcare premiums by an average of about US$ 800 a year for millions of Americans. This move would ensure continued accessibility to health insurance for a broader segment of the population.However, her stance on insurance companies and Big Pharma, including her support for “march-in” rights, might face resistance from pharmaceutical companies concerned about maintaining incentives for innovation.On the issue of drug pricing, Trump’s record is mixed. While he took credit for some decreases in prescription drug prices during his presidency, his administration’s most significant regulatory changes often favored pharmaceutical companies.Trump did issue a rule setting up a path to import drugs from Canada and other countries, but this initiative has faced significant hurdles, including pushback from Canadian authorities.Trump’s stance on drug pricing for a potential second term appears to focus on increasing generic and biosimilar competition, importing drugs made in the US but sold overseas back to the US, and capping out-of-pocket insulin costs. While he has criticized Big Pharma for putting profits above people, his administration’s policies had often aligned with industry interests.Harris appears committed to drug control; Trump had cut public health fundsMental health and substance abuse are the other areas where Harris has shown strong commitment. Having prosecuted drug traffickers, she has demonstrated her commitment to curbing the opioid epidemic.In the White House, she helped direct more than US$ 150 billion to disrupt the flow of illicit drugs and delivered billions of dollars in investments to states to fund lifesaving programs. Under a Harris administration, we might see increased funding for addiction treatment programs and continued efforts to make overdose-reversal drugs like naloxone more accessible.During his presidency, Trump had significantly reduced funding for public health programs. His administration had suggested budget cuts to the Centers for Disease Control and Prevention (CDC) and other public health agencies, justifying them as measures for fiscal responsibility.Our viewGiven her record, a Harris presidency could lead to increased insurance coverage. However, it might also come with increased regulation and price controls. More aggressive drug price negotiations could pressure pharmaceutical companies’ profit margins, potentially affecting R&D budgets. Stricter vigilance on the pharmaceutical industry could lead to more litigation and regulatory challenges for drug companies. But in the long run, this might also improve public trust in drug companies and in the healthcare systems.Under a second Trump term, reduced public health funding could create challenges for community health providers and public health initiatives. An emphasis on generic competition could pressure brand-name drug manufacturers, but create opportunities for generic drug makers.

Impressions: 518

https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices

#Phispers by PHARMACOMPASS
26 Sep 2024

NEWS #PharmaBuzz

read-more
read-more

https://www.merck.com/news/merck-provides-update-on-phase-3-keyform-007-trial-evaluating-investigational-fixed-dose-combination-of-favezelimab-and-pembrolizumab-for-patients-with-previously-treated-pd-l1-positive-microsatellite/

PRESS RELEASE
26 Sep 2024

https://www.fiercepharma.com/pharma/ahead-adcomm-fda-challenges-pd-1-drug-classs-broad-use-stomach-cancer-patients

FIERCE PHARMA
24 Sep 2024

https://www.businesswire.com/news/home/20240919651678/en

BUSINESSWIRE
20 Sep 2024

https://www.businesswire.com/news/home/20240917471670/en/Patritumab-Deruxtecan-Demonstrated-Statistically-Significant-Improvement-in-Progression-Free-Survival-Versus-Doublet-Chemotherapy-in-Patients-with-Locally-Advanced-or-Metastatic-EGFR-Mutated-Non-Small-Cell-Lung-Cancer-in-HERTHENA-Lung02-Phase-3-Trial

BUSINESSWIRE
18 Sep 2024

https://www.fiercebiotech.com/cro/amgen-and-merck-become-first-industry-partners-academic-clinical-trial-diversity-initiative

FIERCE BIOTECH
16 Sep 2024

https://www.businesswire.com/news/home/20240915454590/en

BUSINESSWIRE
15 Sep 2024

USDMF

read-more
read-more

03

BioProcess International
Not Confirmed
arrow

04

BioProcess International
Not Confirmed
arrow

05

BioProcess International
Not Confirmed
arrow

06

BioProcess International
Not Confirmed
arrow

07

BioProcess International
Not Confirmed
arrow

09

BioProcess International
Not Confirmed
arrow

10

BioProcess International
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more

01

Betamethasone

CEP/COS

BioProcess International
Not Confirmed
arrow

02

BioProcess International
Not Confirmed
arrow

03

Ivermectin

CEP/COS

BioProcess International
Not Confirmed
arrow

04

BioProcess International
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-more

01

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 224MF10129

Registrant's Address : 50 Tuas West Drive Singapore 638408

Initial Date of Registration : 2012-07-19

Latest Date of Registration : 2012-07-19

blank

02

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 218MF10865

Registrant's Address : 50 Tuas West Drive Singapore 638408

Initial Date of Registration : 2006-11-06

Latest Date of Registration : 2014-03-13

blank

03

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 218MF10825

Registrant's Address : 50 Tuas West Drive Singapore 638408

Initial Date of Registration : 2006-10-20

Latest Date of Registration : 2014-03-13

blank

04

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 218MF10890

Registrant's Address : 50 Tuas West Drive Singapore 638408

Initial Date of Registration : 2006-11-10

Latest Date of Registration : 2008-06-30

blank

05

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 217MF10593

Registrant's Address : Ballydine, Kilsheelan, Clonmel, Co. Tipperary, Ireland

Initial Date of Registration : 2005-09-14

Latest Date of Registration : 2014-03-06

blank

06

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 231MF10016

Registrant's Address : 50 Tuas West Drive Singapore 638408

Initial Date of Registration : 2019-01-23

Latest Date of Registration : 2019-01-23

blank

07

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

MSD INTL GMBH

Registration Number : 305MF10105

Registrant's Address : 50 Tuas West Drive Singapore 638408

Initial Date of Registration : 2023-08-30

Latest Date of Registration : 2023-08-30

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Services

Upload your portfolio for free, ask us

API & Drug Product Development

Click here to discover the service providers for API & Drug Product Development

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

All Excipients

read-more
read-more

01

PRODUCT 8198 TABLETING AID T

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

PRODUCT 8198 TABLETING AID T

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

POLYVINYL ACETATE-CROTONIC ACID COP...

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioProcess International
Not Confirmed
arrow

POLYVINYL ACETATE-CROTONIC ACID COP...

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioProcess International
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

POLYVINYL ACETATE-CROTONIC A...

BioProcess International
Not Confirmed
arrow

POLYVINYL ACETATE-CROTONIC A...

arrow
BioProcess International
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 11859

Submission : 1996-02-16

Status : Inactive

Type : IV

blank

02

PRODUCT 8198 TABLETING AID T

BioProcess International
Not Confirmed
arrow

PRODUCT 8198 TABLETING AID T

arrow
BioProcess International
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3796

Submission : 1980-05-01

Status : Inactive

Type : IV

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8020

Start Marketing Date : 2019-05-16

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (0.8kg/kg)

Marketing Category : DRUG FOR FURTHER PRO...

blank

02

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8030

Start Marketing Date : 2019-05-16

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (0.785kg/kg)

Marketing Category : DRUG FOR FURTHER PRO...

blank

03

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8040

Start Marketing Date : 2019-05-16

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (0.78kg/kg)

Marketing Category : DRUG FOR FURTHER PRO...

blank

04

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8000

Start Marketing Date : 2018-12-18

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (0.8kg/kg)

Marketing Category : DRUG FOR FURTHER PRO...

blank

05

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8432

Start Marketing Date : 2016-06-15

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (5kg/5kg)

Marketing Category : BULK INGREDIENT

blank

06

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8432

Start Marketing Date : 2014-07-19

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

07

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8432

Start Marketing Date : 2016-02-22

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

BioProcess International
Not Confirmed
arrow
arrow
BioProcess International
Not Confirmed

Merck & Co

NDC Package Code : 14639-8432

Start Marketing Date : 2016-06-15

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view

Inspections and registrations

Upload your audits for free, ask us

EDQM

read-more
read-more

01

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : UK GMP 1373...

EudraGMDP Key : 7740

Country : U.S.A

Issue Date :

Post Code : VA 22827

NCA Ref : 4246-MERCK &...

City : ELKTON

blank

02

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 09/002...

EudraGMDP Key : 7740

Country : U.S.A

Issue Date :

Post Code : VA 22827

NCA Ref : 4246-MERCK &...

City : ELKTON

blank

03

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 09/002...

EudraGMDP Key : 8855

Country : U.S.A

Issue Date :

Post Code : 19486-0004

NCA Ref : 4339-MERCK A...

City : WEST POINT

blank

04

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 10/007...

EudraGMDP Key : 8855

Country : U.S.A

Issue Date :

Post Code : 19486-0004

NCA Ref : 4339-MERCK A...

City : WEST POINT

blank

05

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 10/007...

EudraGMDP Key : 8855

Country : U.S.A

Issue Date :

Post Code : 19486-0004

NCA Ref : 4339-MERCK A...

City : WEST POINT

blank

06

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 10/007...

EudraGMDP Key : 8855

Country : U.S.A

Issue Date :

Post Code : 19486-0004

NCA Ref : 4339-MERCK A...

City : WEST POINT

blank

07

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 11/007...

EudraGMDP Key : 10967

Country : U.S.A

Issue Date :

Post Code : 19486

NCA Ref : PIF/9267

City : West Point, PA

blank

08

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : HMP/PT/23/2...

EudraGMDP Key : 11992

Country : Singapore

Issue Date :

Post Code : 638408

NCA Ref : A015 9625 37...

City : SINGAPORE

blank

09

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 13/011...

EudraGMDP Key : 20275

Country : U.S.A

Issue Date :

Post Code : NC 27712

NCA Ref : 2.0275138306...

City : Durham

blank

10

GMP Certified

EU
BioProcess International
Not Confirmed
arrow

GMP Certified

EU
arrow
BioProcess International
Not Confirmed

Merck & Co

Type : GMP Certificates

Number : NL/H 14/100...

EudraGMDP Key : 10967

Country : U.S.A

Issue Date :

Post Code : 19486

NCA Ref : PIF/9267

City : West Point, PA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Merck & Co. Inc and get a quotation

Merck & Co. Inc is a supplier offers 106 products (APIs, Excipients or Intermediates).

Find a price of Betamethasone bulk with DMF, CEP offered by Merck & Co. Inc

Find a price of Betamethasone bulk with CEP offered by Merck & Co. Inc

Find a price of Ivermectin bulk with CEP offered by Merck & Co. Inc

Find a price of Loratadine bulk with CEP offered by Merck & Co. Inc

Find a price of 2-Methoxyestradiol bulk offered by Merck & Co. Inc

Find a price of 5-N,N-Dibenzylglycyl-Salicylamide bulk offered by Merck & Co. Inc

Find a price of Arprinocid bulk offered by Merck & Co. Inc

Find a price of Brompheniramine Maleate bulk offered by Merck & Co. Inc

Find a price of Butorphanol Tartrate bulk offered by Merck & Co. Inc

Find a price of CAS 50-28-2 bulk offered by Merck & Co. Inc

Find a price of CAS 53-16-7 bulk offered by Merck & Co. Inc

Find a price of Chlorpheniramine Maleate bulk offered by Merck & Co. Inc

Find a price of Conjugated Estrogens bulk offered by Merck & Co. Inc

Find a price of Corticosterone bulk offered by Merck & Co. Inc

Find a price of Danazol bulk offered by Merck & Co. Inc

Find a price of Desogestrel bulk offered by Merck & Co. Inc

Find a price of Dexamethasone bulk offered by Merck & Co. Inc

Find a price of Dexamethasone Sodium Phosphate bulk offered by Merck & Co. Inc

Find a price of Dexbrompheniramine Maleate bulk offered by Merck & Co. Inc

Find a price of Dexchloropheniramine Maleate bulk offered by Merck & Co. Inc

Find a price of Diethylstilbestrol bulk offered by Merck & Co. Inc

Find a price of Diflunisal bulk offered by Merck & Co. Inc

Find a price of Dihydrotestosterone bulk offered by Merck & Co. Inc

Find a price of Diltiazem bulk offered by Merck & Co. Inc

Find a price of Droperidol bulk offered by Merck & Co. Inc

Find a price of Edrophonium Chloride bulk offered by Merck & Co. Inc

Find a price of Enalapril Maleate bulk offered by Merck & Co. Inc

Find a price of Estradiol bulk offered by Merck & Co. Inc

Find a price of Estriol bulk offered by Merck & Co. Inc

Find a price of Ethinyl Estradiol bulk offered by Merck & Co. Inc

Find a price of Fentanyl Citrate bulk offered by Merck & Co. Inc

Find a price of Fluphenazine Decanoate bulk offered by Merck & Co. Inc

Find a price of Guaiazulene bulk offered by Merck & Co. Inc

Find a price of Heparin Sodium bulk offered by Merck & Co. Inc

Find a price of Hyaluronic Acid bulk offered by Merck & Co. Inc

Find a price of Imipramine Hydrochloride bulk offered by Merck & Co. Inc

Find a price of Lovastatin bulk offered by Merck & Co. Inc

Find a price of Medroxyprogesterone Acetate bulk offered by Merck & Co. Inc

Find a price of Megestrol Acetate bulk offered by Merck & Co. Inc

Find a price of Mestranol bulk offered by Merck & Co. Inc

Find a price of Mk-6240 bulk offered by Merck & Co. Inc

Find a price of Mk2048 bulk offered by Merck & Co. Inc

Find a price of Nalbuphine Hydrochloride bulk offered by Merck & Co. Inc

Find a price of Nalmefene Hydrochloride bulk offered by Merck & Co. Inc

Find a price of Naltrexone bulk offered by Merck & Co. Inc

Find a price of Neomycin Sulfate bulk offered by Merck & Co. Inc

Find a price of Norandrostenedione bulk offered by Merck & Co. Inc

Find a price of Norethisterone bulk offered by Merck & Co. Inc

Find a price of Norethisterone Acetate bulk offered by Merck & Co. Inc

Find a price of Norgestimate bulk offered by Merck & Co. Inc

Find a price of Omeprazole Magnesium bulk offered by Merck & Co. Inc

Find a price of Oxandrolone bulk offered by Merck & Co. Inc

Find a price of Oxytocin bulk offered by Merck & Co. Inc

Find a price of Pheniramine Maleate bulk offered by Merck & Co. Inc

Find a price of Pimozide bulk offered by Merck & Co. Inc

Find a price of Prasterone Acetate bulk offered by Merck & Co. Inc

Find a price of Prednisolone bulk offered by Merck & Co. Inc

Find a price of Prednisolone Sodium Phosphate bulk offered by Merck & Co. Inc

Find a price of Prochlorperazine Edisylate bulk offered by Merck & Co. Inc

Find a price of Promethazine Hydrochloride bulk offered by Merck & Co. Inc

Find a price of Pyridostigmine bulk offered by Merck & Co. Inc

Find a price of Testosterone Propionate bulk offered by Merck & Co. Inc

Find a price of Thiabendazole bulk offered by Merck & Co. Inc

Find a price of Thiamine Disulfide bulk offered by Merck & Co. Inc

Find a price of Tibolone bulk offered by Merck & Co. Inc

Find a price of Tubocurarine Chloride bulk offered by Merck & Co. Inc

Find a price of Urofollitropin bulk offered by Merck & Co. Inc

Find a price of Vitamin B12 bulk offered by Merck & Co. Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN HOBBESDON, HERFORDSHIRE, ENGLAND. bulk offered by Merck & Co. Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WILSON, NORTH CAROLINA. bulk offered by Merck & Co. Inc

Find a price of PREPARATION OF TEN STABLE ISOTOPE-LABELLED COMPOUNDS bulk offered by Merck & Co. Inc

Find a price of FACILITIES AND OPERATING PROCEDURES IN CLERMONT-FERRAND,FRANCE bulk offered by Merck & Co. Inc

Find a price of MK-4176 DRUG SUBSTANCE bulk offered by Merck & Co. Inc

Find a price of NITROGEN MUSTARDS bulk offered by Merck & Co. Inc

Find a price of AMPROLIUM IN CHICKENS (VET) bulk offered by Merck & Co. Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Merck & Co. Inc

Find a price of MANUF.CONTROL,FACILITIES &PROCEDURES-AT RAHWAY, NJ PLANT bulk offered by Merck & Co. Inc

Find a price of AMPROL SUPER PLUS (AMPROLIUM & ETHOPABATE) (VET) bulk offered by Merck & Co. Inc

Find a price of MANUF. & CONTROL,FACILITIES & PROCEDURES-FOR ELKTON, VA. PLANT bulk offered by Merck & Co. Inc

Find a price of STERILE DILUENT bulk offered by Merck & Co. Inc

Find a price of FACILITY AND PROCEDURES IN OSS, THE NETHERLANDS - MOLENSTRAAT 110 bulk offered by Merck & Co. Inc

Find a price of PRO-STREP CRUMBLES (VET) bulk offered by Merck & Co. Inc

Find a price of HADACIDIN SOD. DIHYDRATE (NSC 521778) & HADACIDIN POTASS. NSC 72962 bulk offered by Merck & Co. Inc

Find a price of RATHDRUM, COUNTY WICKLOW, IRELAND bulk offered by Merck & Co. Inc

Find a price of HYDROCORT. 21-PHOSPHATE & NEOMYCIN SO4--OPTHAL. SOL. 0.5% & INJECT bulk offered by Merck & Co. Inc

Find a price of CORTATE (DESOXYCORTICOSTERONE ACETATE) bulk offered by Merck & Co. Inc

Find a price of MANUFACTURE AND CONTROL bulk offered by Merck & Co. Inc

Find a price of PROCESS $ CONTROL DATE CONCERNING MANUFACTURE OF 2-ACETYLAMINA ETC. bulk offered by Merck & Co. Inc

Find a price of AMPROLIUM MEDICATED FEED -(3-NITRO-4-HYDROXYPHENYLARSONIC ACID) (VET) bulk offered by Merck & Co. Inc

Find a price of PORCINE INSULIN HIGHLY PURIFIED bulk offered by Merck & Co. Inc

Find a price of L-000825058 bulk offered by Merck & Co. Inc

Find a price of MANUF. CONTROL FACILITIES & PROCEDURES FOR DANVILLE PA PLANT bulk offered by Merck & Co. Inc

Find a price of ORG 32489 RECOMBINANT FSH bulk offered by Merck & Co. Inc

Find a price of 1-METHYL-1-(B-CHLOROETHYL) ETHYLENIMONIUM PICRYSULFONATE bulk offered by Merck & Co. Inc

Find a price of BULK FORM OF DRUG PRODUCT L-590,153 PROCESSED RAHWAY, N.J. FACILITIES bulk offered by Merck & Co. Inc

Find a price of MERCK bulk offered by Merck & Co. Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN OKAZAKI CITY, JAPAN. bulk offered by Merck & Co. Inc

Find a price of FACILS., METHODS & CONTROLS FOR PROCESSING & PACKAGING OF DRUG PRODS. bulk offered by Merck & Co. Inc

Find a price of TECHNETIUM Tc 99M POLYPHOSPHATE KIT bulk offered by Merck & Co. Inc

Find a price of PRO-STREP IN SWINE (VET) bulk offered by Merck & Co. Inc

Find a price of MANUF&CONTROL FACILITIES&PROCEDURES AT SUBSIDIARY PLANT BARCELONETA,PR bulk offered by Merck & Co. Inc

Find a price of MANUF, CONTROL FACILITIES PROCEDURES FOR ALBANY, GA. PLANT bulk offered by Merck & Co. Inc

Find a price of L-651,392-00N,4-BROMO-2,7-DIMETHOXY-3H-PHENOTHIAZIN-3-ONE bulk offered by Merck & Co. Inc

Find a price of NORGESTOMET bulk offered by Merck & Co. Inc

Find a price of J-107088 bulk offered by Merck & Co. Inc

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN LE PUY CEDEX, FRANCE. bulk offered by Merck & Co. Inc

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty